Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (11 quarters reported)
$864M in Q2 2020 → $47.6M now. Hover for any quarter.
As reported for the quarter ended September 30, 2024. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| 10x Genomics Inc | 100.0% | Unchanged | 2,106,757 | $47.6M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2024 · filed November 14, 2024
No position changes this quarter.
quarter ended June 30, 2024 · filed August 14, 2024
No position changes this quarter.
quarter ended March 31, 2024 · filed May 15, 2024
No position changes this quarter.
quarter ended December 31, 2023 · filed February 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| 10x Genomics Inc | Added | +1,144,448 | +$64M | 100.0% |
| CH Castlight Health Inc | Exited | −3,707,442 | −$5.71M | — |
quarter ended December 31, 2021 · filed February 14, 2022
No position changes this quarter.
quarter ended September 30, 2021 · filed November 15, 2021
No position changes this quarter.
quarter ended June 30, 2021 · filed August 13, 2021
No position changes this quarter.
quarter ended March 31, 2021 · filed May 14, 2021
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| 10x Genomics Inc | Trimmed | −927,188 | −$168M | 96.9% |
Loading...
